# Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

> **NCT01181999** · PHASE2 · UNKNOWN · sponsor: **Chonnam National University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Lymphoma, Large B-cell, Diffuse

## Interventions

- **DRUG:** rituximab

## Key facts

- **NCT ID:** NCT01181999
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2012-03
- **Final completion:** 2014-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-09-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181999, "Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*